Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.58 |
| ▸ | CA2 | P00918 | 5/20 | 0.58 |
| ▸ | CA9 | Q16790 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | CHRM2 | P08172 | 8/20 | 0.50 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.50 |
| ▸ | MPO | P05164 | 1/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.49 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 3/20 | 0.46 |
| ▸ | BCHE | P06276 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15745844 | 0.96 | CA12 (0.58) | CA12CA2CA9KDM4ETSHR | |
| SCHEMBL6348034 | 0.93 | LIPG (0.56) | CA12CA2CA9KDM4ETSHR | |
| SCHEMBL237159 | 0.89 | LIPG (0.47) | CA12CA2CA9KDM4ETSHR | |
| SCHEMBL26009770 | 0.89 | LIPG (0.50) | CA12CA2CA9KDM4ETSHR | |
| SCHEMBL1700582 | 0.88 | CHRM2 (0.56) | CA12CA2CA9KDM4ETSHR | |
| SCHEMBL30253962 | 0.88 | CHRM2 (0.56) | CA12CA2CA9KDM4ETSHR | |
| SCHEMBL6352960 | 0.87 | MPO (0.65) | LIPGMPOSLC6A4BCHE | |
| SCHEMBL10457529 | 0.85 | SCN8A (0.48) | CA12CA2CA9KDM4ETSHR | |
| SCHEMBL13287109 | 0.84 | LIPG (0.48) | CA12CA2CA9KDM4ETSHR | |
| SCHEMBL10457527 | 0.83 | CA12 (0.45) | CA12CA2CA9TSHRCHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9970940-B2 | Barrier layer for glucose sensor | LIGHTSHIP MEDICAL LIMITED (GB) | 2018-05-15 | — | — | US | disclosed |
| US-9797909-B2 | Sensor | LIGHTSHIP MEDICAL LIMITED (GB) | 2017-10-24 | — | — | US | disclosed |
| US-20170010274-A1 | SENSOR | VANTIVE HEALTH GMBH (CH) | 2017-01-12 | — | — | US | disclosed |
| US-9476886-B2 | Sensor | LIGHTSHIP MEDICAL LIMITED (GB) | 2016-10-25 | — | — | US | disclosed |
| US-20160178638-A1 | Glucose Sensor Molecule | VANTIVE HEALTH GMBH (CH) | 2016-06-23 | — | — | US | disclosed |
| US-9222941-B2 | Glucose sensor molecules | LIGHTSHIP MEDICAL LIMITED (GB) | 2015-12-29 | — | — | US | disclosed |
| US-20150219663-A1 | SENSOR | LIGHTSHIP MEDICAL LIMITED (GB) | 2015-08-06 | — | — | US | disclosed |
| US-8940542-B2 | Sensor | Lighthouse Medical Limited (GB) | 2015-01-27 | — | — | US | disclosed |
| US-20140349307-A1 | Barrier Layer for Glucose Sensor | ARES CAPITAL CORPORATION | 2014-11-27 | — | — | US | disclosed |
| US-20140234982-A1 | SENSOR | LIGHTSHIP MEDICAL LIMITED (GB) | 2014-08-21 | — | — | US | disclosed |
| US-20140147934-A1 | Glucose sensor molecules | ARES CAPITAL CORPORATION | 2014-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160178638-A1 | Glucose Sensor Molecule | GPR119, GCKR, IRS1 | CA12 2225/4885CA2 1316/4885CA9 1931/4885 |
| US-20140147934-A1 | Glucose sensor molecules | GPR119, GCKR, IRS1 | CA12 2296/4885CA2 1269/4885CA9 1827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.